La Hey E, Baarsma G S, De Vries J, Kijlstra A
The Netherlands Ophthalmic Research Institute, Amsterdam.
Doc Ophthalmol. 1991;78(3-4):225-35. doi: 10.1007/BF00165685.
Fuchs' heterochromic cyclitis (FHC) is an important diagnosis to make. Not only for the patient, because incorrect diagnosis may lead to unnecessary therapy and the failure to detect secondary glaucoma, but also for the comparison of studies on the etiology of FHC, which is still unknown. No clinical criteria for establishing the diagnosis of FHC have been internationally accepted yet. By means of clinical analyses of FHC patients in different parts of the world, predominant clinical features may be distinguished and combined to form (internationally accepted) diagnostic criteria. We report a clinical analysis of 51 FHC patients in the Netherlands. Acute symptoms (severe redness, pain or photophobia) were never (100%) encountered. Characteristic keratic precipitates (88%) and/or minimal aqueous cells and flare (60%) and/or vitreous opacities (84%) were major signs, indicating a chronic inflammatory activity, in which no synechiae (100%) were present. Heterochromia (82%) was not a constant sign, but iris stromal atrophy, which causes the heterochromia, was always present (100%). Cataract was present in 82% as a result of the chronic iridocyclitis. Secondary glaucoma was present in 22%. Based on the predominant clinical findings obtained from this analysis of FHC patients, and on data in the literature, we propose clinical diagnostic criteria for FHC. Future studies, also including other uveitis groups, are necessary to confirm these diagnostic criteria.
富克斯异色性睫状体炎(FHC)是一项需要做出的重要诊断。这不仅对患者很重要,因为错误诊断可能导致不必要的治疗以及无法检测到继发性青光眼,而且对于FHC病因研究的比较也很重要,目前FHC的病因仍不清楚。国际上尚未接受用于确立FHC诊断的临床标准。通过对世界各地FHC患者的临床分析,可以区分并综合主要临床特征以形成(国际认可的)诊断标准。我们报告了对荷兰51例FHC患者的临床分析。从未出现过急性症状(严重眼红、疼痛或畏光)(100%)。特征性角膜后沉着物(88%)和/或少量房水细胞及闪光(60%)和/或玻璃体混浊(84%)是主要体征,表明存在慢性炎症活动,其中不存在虹膜粘连(100%)。异色症(82%)并非始终存在的体征,但导致异色症的虹膜基质萎缩总是存在(100%)。由于慢性虹膜睫状体炎,82%的患者存在白内障。22%的患者存在继发性青光眼。基于对FHC患者的这一分析所获得的主要临床发现以及文献中的数据,我们提出了FHC的临床诊断标准。未来还需要开展包括其他葡萄膜炎组在内的研究来证实这些诊断标准。